Catalyst Wire Dossier Catalyst Wire Dossier

ezutromid

SMT C1100 · Summit Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ezutromid, covering 2020-01-02 to 2020-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Proof of Concept Study to Assess Activity and Safety of SMT C1100 (Ezutromid) in Boys With Duchenne Muscular Dystrophy (DMD) [Phase 2]

See pricing